Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

1.

Cryptococcosis in sarcoidosis: cryptOsarc, a comparative study of 18 cases.

Bernard C, Maucort-Boulch D, Varron L, Charlier C, Sitbon K, Freymond N, Bouhour D, Hot A, Masquelet AC, Valeyre D, Costedoat-Chalumeau N, Etienne M, Gueit I, Jouneau S, Delaval P, Mouthon L, Pouget J, Serratrice J, Brion JP, Vaylet F, Bremont C, Chennebault JM, Jaffuel S, Broussolle C, Lortholary O, Sève P; French Cryptococcosis Study Group.

QJM. 2013 Jun;106(6):523-39. doi: 10.1093/qjmed/hct052. Epub 2013 Mar 19. Review.

PMID:
23515400
[PubMed - indexed for MEDLINE]
Free Article
2.

Major role for amphotericin B-flucytosine combination in severe cryptococcosis.

Dromer F, Bernede-Bauduin C, Guillemot D, Lortholary O; French Cryptococcosis Study Group.

PLoS One. 2008 Aug 6;3(8):e2870. doi: 10.1371/journal.pone.0002870.

PMID:
18682846
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era.

Charlier C, Dromer F, Lévêque C, Chartier L, Cordoliani YS, Fontanet A, Launay O, Lortholary O; French Cryptococcosis Study Group.

PLoS One. 2008 Apr 16;3(4):e1950. doi: 10.1371/journal.pone.0001950.

PMID:
18414656
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Determinants of disease presentation and outcome during cryptococcosis: the CryptoA/D study.

Dromer F, Mathoulin-Pélissier S, Launay O, Lortholary O; French Cryptococcosis Study Group.

PLoS Med. 2007 Feb;4(2):e21.

PMID:
17284154
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Results obtained with various antifungal susceptibility testing methods do not predict early clinical outcome in patients with cryptococcosis.

Dannaoui E, Abdul M, Arpin M, Michel-Nguyen A, Piens MA, Favel A, Lortholary O, Dromer F; French Cryptococcosis Study Group.

Antimicrob Agents Chemother. 2006 Jul;50(7):2464-70.

PMID:
16801427
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France.

Lortholary O, Fontanet A, Mémain N, Martin A, Sitbon K, Dromer F; French Cryptococcosis Study Group.

AIDS. 2005 Jul 1;19(10):1043-9.

PMID:
15958835
[PubMed - indexed for MEDLINE]
7.

Evidence for human immunodeficiency virus and Cryptococcus neoformans interactions in the pro-inflammatory and anti-inflammatory responses in blood during AIDS-associated cryptococcosis.

Lortholary O, Sitbon K, Dromer F; French Cryptococcosis Study Group.

Clin Microbiol Infect. 2005 Apr;11(4):296-300.

PMID:
15760426
[PubMed - indexed for MEDLINE]
8.

Epidemiology of HIV-associated cryptococcosis in France (1985-2001): comparison of the pre- and post-HAART eras.

Dromer F, Mathoulin-Pélissier S, Fontanet A, Ronin O, Dupont B, Lortholary O; French Cryptococcosis Study Group.

AIDS. 2004 Feb 20;18(3):555-62.

PMID:
15090810
[PubMed - indexed for MEDLINE]
9.

Primary cutaneous cryptococcosis: a distinct clinical entity.

Neuville S, Dromer F, Morin O, Dupont B, Ronin O, Lortholary O; French Cryptococcosis Study Group.

Clin Infect Dis. 2003 Feb 1;36(3):337-47. Epub 2003 Jan 17.

PMID:
12539076
[PubMed - indexed for MEDLINE]
Free Article
10.

Immune mediators in cerebrospinal fluid during cryptococcosis are influenced by meningeal involvement and human immunodeficiency virus serostatus.

Lortholary O, Dromer F, Mathoulin-Pélissier S, Fitting C, Improvisi L, Cavaillon JM, Dupont B; French Cryptococcosis Study Group.

J Infect Dis. 2001 Jan 15;183(2):294-302. Epub 2000 Dec 8.

PMID:
11110651
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk